Gene · 5132
Papers1,377
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,377
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances of Peptide-Drug Conjugates in the Treatment of Digestive System Tumors. | Drug Des Devel Ther | 2026 | 42802838 | PubTator, text mining | PubMed |
| Peptide-drug conjugates in breast cancer therapy: Emerging targets, translational challenges, and optimization strategies. | J Pharmacol Exp Ther | 2026 | 42790198 | PubTator, text mining | PubMed |
| Stress-driven reprogramming of plasmacytoid dendritic cells in intrahepatic cholangiocarcinoma defines a reversible targetable immunosuppressive state. | World J Surg Oncol | 2026 | 42760567 | PubTator, text mining | PubMed |
| Priming Cells with Modulators of Cellular Signaling Ensures Enhanced Selectivity of HSPG-Specific Protein-Drug Conjugate Delivery. | J Am Chem Soc | 2026 | 42714551 | PubTator, text mining | PubMed |
| Irradiation-Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK. | Immunology | 2026 | 42686427 | PubTator, text mining | PubMed |
| Engineering peptide-drug conjugates for targeted cancer therapy: design principle, theranostic imaging, and translational challenges. | Adv Drug Deliv Rev | 2026 | 42674319 | PubTator, text mining | PubMed |
| Integrated Patient-Derived Xenograft and Patient-Derived Cell Models Reveal Therapeutic Vulnerabilities Beyond Standard-of-Care Therapy in Endometrial Cancer. | bioRxiv | 2026 | 42619684 | PubTator, text mining | PubMed |
| Abexinostat attenuates temozolomide-resistant glioma stem cells. | Neuro Oncol | 2026 | 42616000 | PubTator, text mining | PubMed |
| TPGS Analog-Mediated Intracellular ROS-Amplifying Strategy Potentiates the In Vitro Anticancer Activity of a Dual-Thioketal-Linked Polymeric Drug Conjugate in A549 Lung Cancer Cells. | Pharmaceutics | 2026 | 42514963 | PubTator, text mining | PubMed |
| Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications. | Pharmacol Res | 2026 | 42468581 | PubTator, text mining | PubMed |
| The emerging clinical relevance of cell-free DNA in lupus: from mechanistic insights to therapeutic opportunities. | Front Immunol | 2026 | 42416073 | PubTator, text mining | PubMed |
| Anserine restores antibacterial immunity in cirrhosis via protective CCL5-mediated hepatocyte-CD44+ pDC crosstalk. | J Hepatol | 2026 | 42385859 | PubTator, text mining | PubMed |
| Diagnostic value of basic and extended procedures in pediatric fever of unknown origin - results of a nation-wide surveillance study. | Mol Cell Pediatr | 2026 | 42377852 | PubTator, text mining | PubMed |
| Metabolic rewiring of Phanerochaete chrysosporium to enhance tolerance and degradation of aged polystyrene microplastics: Pyruvate metabolism and actin polarization. | J Hazard Mater | 2026 | 42320097 | PubTator, text mining | PubMed |
| Alkaline woody peat shifts CO2 emissions to CH4 by modulating microbial cross-feeding in Cd-contaminated paddy soil. | J Hazard Mater | 2026 | 42242079 | PubTator, text mining | PubMed |
| Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer. | J Immunother Cancer | 2026 | 42236117 | PubTator, text mining | PubMed |
| AI-Driven Design and Clinical Translation of Nucleotide-Peptide and Peptide-Drug Conjugates. | ACS Biomater Sci Eng | 2026 | 42228500 | PubTator, text mining | PubMed |
| Self-Assembly of Peptide-Lipid Platinum(IV) Prodrug Amphiphile for αvβ3 Integrin-Targeting Chemotherapy. | Adv Healthc Mater | 2026 | 42216428 | PubTator, text mining | PubMed |
| Peptide-DNA Conjugates for Formation of Lipid Nanodiscs. | bioRxiv | 2026 | 42182361 | PubTator, text mining | PubMed |
| A genome-wide deletion map in 125,730 individuals for novel rare disease gene and variant discovery. | medRxiv | 2026 | 42180369 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5132/papers